Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-World Databases
May 2024
in “
The World Journal of Men s Health
”
TLDR Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.
The study analyzed data from 15 real-world databases to compare the effects of dutasteride and finasteride on the risk of prostate cancer in patients with benign prostatic hyperplasia (BPH). The findings indicated that dutasteride did not offer a lower risk of prostate cancer compared to finasteride in these patients.